The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Belfer Gene Therapy Core Facility is overseen by Associate Directors Stephen Kaminsky and Dolan Sondhi (not pictured), and employs a diverse group of technicians, post-doctoral researchers, and senior scientists. Front row form left: Sheykha Gada, Julia Chopey ,Casandra Cholula, Andreane Syra Cruz, Tahira Hasan, Isabelle Wilson, Shawna McGoldrick, Cheyenne Mcknight; 2nd row from left: Sara Cram, Louis DeLucia, Meghan Herlitzka, Athira Lalu, Jada Scotland, Kimberly Castaneda, Rachel Spokony; Last row from left: Abhishek Bose, Emmanuel Opoku, Stephen Kaminsky, Caner Günaydin, Bishnu De, Christiana Oluwaseun Salami, Kalpita Rashmi, Phillip Joseph Necaise, Hailey Lephart, Sadia Shahbazi, Nicholas Gorman, Jenifer Vasquez, Jonathan Rosenberg, William Pascal, Mara Kebret, and Chitra Mohan.